scholarly journals Boron distribution in the normal rat brain after intravenous injection of boronophenylalanine-fructose

2007 ◽  
Vol 87 (1) ◽  
pp. 35-41 ◽  
Author(s):  
Yasushi Shibata
2004 ◽  
Vol 79 (6) ◽  
pp. 494 ◽  
Author(s):  
Feng Jiang ◽  
Zheng Gang Zhang ◽  
Mark Katakowski ◽  
Adam M Robin ◽  
Michelle Faber ◽  
...  

2002 ◽  
Vol 22 (12) ◽  
pp. 1476-1489 ◽  
Author(s):  
Nancy F. Cruz ◽  
Gerald A. Dienel

The concentration of glycogen, the major brain energy reserve localized mainly in astrocytes, is generally reported as about 2 or 3 μmol/g, but sometimes as high as 3.9 to 8 μmol/g, in normal rat brain. The authors found high but very different glycogen levels in two recent studies in which glycogen was determined by the routine amyloglucosidase procedure in 0.03N HCl digests either of frozen powders (4.8 to 6 μmol/g) or of ethanol-insoluble fractions (8 to 12 μmol/g). To evaluate the basis for these discrepant results, glycogen was assayed in parallel extracts of the same samples. Glycogen levels in ethanol extracts were twice those in 0.03N HCl digests, suggesting incomplete enzyme inactivation even with very careful thawing. The very high glycogen levels were biologically active and responsive to physiologic and pharmacological challenge. Glycogen levels fell after brief sensory stimulation, and metabolic labeling indicated its turnover under resting conditions. About 95% of the glycogen was degraded under in vitro ischemic conditions, and its “carbon equivalents” recovered mainly as glc, glc-P, and lactate. Resting glycogen stores were reduced by about 50% by chronic inhibition of nitric oxide synthase. Because neurotransmitters are known to stimulate glycogenolysis, stress or sensory activation due to animal handling and tissue-sampling procedures may stimulate glycogenolysis during an experiment, and glycogen lability during tissue sampling and extraction can further reduce glycogen levels. The very high glycogen levels in normal rat brain suggest an unrecognized role for astrocytic energy metabolism during brain activation.


1992 ◽  
Vol 22 (11) ◽  
pp. 2963-2971 ◽  
Author(s):  
Hong Qu Yan ◽  
Miguel Alcaros Banos ◽  
Patrick Herregodts ◽  
Robert Hooghe ◽  
Elisabeth L. Hooghe-Peters
Keyword(s):  

1984 ◽  
Vol 4 (2) ◽  
pp. 275-283 ◽  
Author(s):  
Shigeharu Takagi ◽  
Kazumasa Ehara ◽  
Peter J. Kenny ◽  
Ronald D. Finn ◽  
Paresh J. Kothari ◽  
...  

No method has been reported for measuring CBF, repeatedly and noninvasively, in the rat brain. A new method is described, which is noninvasive to the brain, skull, or cervical large vessels. Two pairs of coincidence detectors were positioned, one over the rat brain and the other at the loop of a catheter inserted into the femoral artery. The coincidence head curve and arterial curve were recorded after intravenous injection of 1-[11C]butanol in 15 rats. CBF was calculated by one-compartment curve fitting (CBFo) from 1-min data and with the recirculation corrected height/area method from 3-min data (CBFh · 3min) and 5-min data (CBFh · 5min). CBFo agreed well with CBFh · 5min, although a slight overestimation was observed in CBFh · 3min. The normal CBFo in the normocapnic group (n = 6, paco2 36.7 ± 2.3 mm Hg) was 1.76 ± 0.49 ml/g min (mean ± SD). A good correlation was observed between CBFo ( y) and Paco2 ( x), and the regression line was y = 0.0629 x – 0.715 (r = 0.88, p < 0.0001). We concluded that this method gives the stable blood flow values noninvasively and with a minimum loss of blood (<0.28 ml per measurement). Applications of this method include activation studies, studies on the effect of drugs and treatments, and water and oxygen extraction fraction studies using different tracers in the same rat.


1993 ◽  
Vol 63 (1) ◽  
pp. 173-180 ◽  
Author(s):  
Tsuneo Yamazaki ◽  
Haruyasu Yamaguchi ◽  
Takeshi Kawarabayashi ◽  
Shunsaku Hirai

1990 ◽  
pp. 25-27
Author(s):  
F. Ohta ◽  
K. Moritake ◽  
T. Kagawa ◽  
M. Fukuda ◽  
A. Fukuma

1992 ◽  
Vol 56 (3) ◽  
pp. 379-384 ◽  
Author(s):  
Qun Chen ◽  
Brian C. Wilson ◽  
Mary O. Dereski ◽  
Michael S. Patterson ◽  
Michael Chopp ◽  
...  

1985 ◽  
Vol 23 (5) ◽  
pp. 475-482 ◽  
Author(s):  
Tatsuhito Yamagami ◽  
Hajime Handa ◽  
Juji Takeuchi ◽  
Nobuo Hashimoto ◽  
Waro Taki ◽  
...  

1991 ◽  
Vol 260 (3) ◽  
pp. F466-F469 ◽  
Author(s):  
O. Meirav ◽  
R. A. Sutton ◽  
D. Fink ◽  
R. Middleton ◽  
J. Klein ◽  
...  

The advent of accelerator mass spectrometry (AMS) now permits the ultrasensitive detection of extremely long-lived isotopes, including 14C, 26Al, and 41Ca. Until now, tracer studies of aluminum kinetics have not been possible because aluminum has only two isotopes, with half-lives of 6.5 min (29Al) and 7 x 10(5) yr (26Al), neither of which is suitable for conventional studies. In a novel experiment we have employed AMS to study aluminum kinetics in a normal rat and a 5/6-nephrectomized rat over a 3-wk period of intravenous injection of a tracer dose of 26Al. Kinetics were similar in the two animals; approximately 75% of intravenously injected tracer 26Al was excreted in the urine in the first 24 h as was approximately 80% after 3 wk. Renal clearance of 26Al was approximately 0.75 ml.min-1.kg body wt-1 in both rats. The results clearly demonstrate the potential of this technique for isotope tracer studies in animals as well as in humans.


Sign in / Sign up

Export Citation Format

Share Document